EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 34 (October 2018) Focus issue F1 Med Sci (Paris), 34 (2018) 33-38 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 33 - 38
DOI https://doi.org/10.1051/medsci/201834f106
Publié en ligne 7 novembre 2018
  1. Pandiani C, Beranger GE, Leclerc J, et al. Focus on cutaneous and uveal melanoma specificities. Genes Dev 2017 ; 31 : 724–743. [CrossRef] [PubMed] [Google Scholar]
  2. Millet A, Martin AR, Ronco C, et al. Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges. Med Res Rev 2017 ; 37 : 98–148. [CrossRef] [PubMed] [Google Scholar]
  3. Lim SY, Menzies AM, Rizos H. Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma. Cancer 2017 ; 123 : 2118–2129. [CrossRef] [PubMed] [Google Scholar]
  4. Volpe VO, Klufas DM, Hegde U, Grant-Kels JM. The new paradigm of systemic therapies for metastatic melanoma. J Am Acad Dermatol 2017 ; 77 : 356–368. [CrossRef] [PubMed] [Google Scholar]
  5. Shanmugam MK, Lee JH, Chai EZ, et al. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. Semin Cancer Biol 2016 ; 40–41 : 35–47. [CrossRef] [PubMed] [Google Scholar]
  6. Xiao Z, Morris-Natschke SL, Lee KH. Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates. Med Res Rev 2016 ; 36 : 32–91. [CrossRef] [PubMed] [Google Scholar]
  7. Fangjun L, Zhijia Y. Tumor suppressive roles of eugenol in human lung cancer cells. Thorac Cancer 2017. [Google Scholar]
  8. Ghavre M, Froese J, Pour M, Hudlicky T. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives. Angew Chem Int Ed Engl 2016 ; 55 : 5642–5691. [CrossRef] [PubMed] [Google Scholar]
  9. Kang J, Zhang Y, Cao X, et al. Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge. Int Immunopharmacol 2012 ; 12 : 249–256. [CrossRef] [PubMed] [Google Scholar]
  10. Guo Y, Wang Y, Cao L, et al. A Conserved Inhibitory Mechanism of a Lycorine Derivative against Enterovirus and Hepatitis C Virus. Antimicrob Agents Chemother 2016 ; 60 : 913–924. [CrossRef] [PubMed] [Google Scholar]
  11. Roy M, Liang L, Xiao X, et al. Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma. Theranostics 2016 ; 6 : 2209–2224. [CrossRef] [PubMed] [Google Scholar]
  12. Hu M, Peng S, He Y, et al. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer. Oncotarget 2015 ; 6 : 15348–15361. [PubMed] [Google Scholar]
  13. Yu H, Qiu Y, Pang X, et al. Lycorine promotes autophagy and apoptosis via TCRP1/Akt/mTOR axis inactivation in human hepatocellular carcinoma. Mol Cancer Ther 2017. [Google Scholar]
  14. Subramaniam S, Sundarasekar J, Sahgal G, Murugaiyah V. Comparative analysis of lycorine in wild plant and callus culture samples of Hymenocallis littoralis by HPLC-UV method. ScientificWorldJournal 2014 ; 2014 : 408306. [CrossRef] [PubMed] [Google Scholar]
  15. Nair JJ, van Staden J, Bastida J. Apoptosis-Inducing Effects of Amaryllidaceae Alkaloids. Curr Med Chem 2016 ; 23 : 161–185. [CrossRef] [PubMed] [Google Scholar]
  16. Nair JJ, van Staden J. Cytotoxicity studies of lycorine alkaloids of the Amaryllidaceae. Nat Prod Commun 2014 ; 9 : 1193–1210. [Google Scholar]
  17. Wang J, Xu J, Xing G. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway. Acta Biochim Biophys Sin (Shanghai) 2017 ; 49 : 771–779. [CrossRef] [PubMed] [Google Scholar]
  18. Wang C, Wang Q, Li X, et al. Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade. Biochem Biophys Res Commun 2017 ; 483 : 197–202. [CrossRef] [Google Scholar]
  19. Zhao D, Han W, Liu X, et al. MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2. Thorac Cancer 2017 ; 8 : 304–311. [CrossRef] [PubMed] [Google Scholar]
  20. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011 ; 144 : 646–674. [CrossRef] [PubMed] [Google Scholar]
  21. Park S, Chapuis N, Tamburini J, et al. Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica 2010 ; 95 : 819–828. [CrossRef] [PubMed] [Google Scholar]
  22. Yoshikawa Y, Takano O, Kato I, et al. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1alpha pathway. Cancer Lett 2017 ; 410 : 82–91. [CrossRef] [Google Scholar]
  23. Yin K, Wang L, Zhang X, et al. Netrin-1 promotes gastric cancer cell proliferation and invasion via the receptor neogenin through PI3K/AKT signaling pathway. Oncotarget 2017 ; 8 : 51177–51189. [PubMed] [Google Scholar]
  24. Hu B, Lv X, Gao F, et al. Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway. OncoTargets and therapy 2017 ; 10 : 4379–4391. [CrossRef] [PubMed] [Google Scholar]
  25. Wei Y, Wu S, Xu W, et al. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP. Thorac Cancer 2017 ; 8 : 26–32. [CrossRef] [PubMed] [Google Scholar]
  26. Basho RK, Gilcrease M, Murthy RK, et al. Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab. JAMA Oncol 2017 ; 3 : 509–515. [CrossRef] [PubMed] [Google Scholar]
  27. Calero R, Morchon E, Martinez-Argudo I, Serrano R. Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma. Cancer Lett 2017 ; 406 : 1–11. [CrossRef] [Google Scholar]
  28. Choi EO, Cho EJ, Jeong JW, et al. Baicalein Inhibits the Migration and Invasion of B16F10 Mouse Melanoma Cells through Inactivation of the PI3K/Akt Signaling Pathway. Biomol Ther (Seoul) 2017 ; 25 : 213–221. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.